IP Archives of Cytology and Histopathology Research
Official Publication of Khyati Education and Research Foundation
Official Publication of Khyati Education and Research Foundation
Print ISSN: 2581-5725
Online ISSN: 2456-9267
CODEN : IACHCL
IP Archives of Cytology and Histopathology Research (ACHR) open access, peer-reviewed quarterly journal publishing since 2016 and is published under the Khyati Education and Research Foundation (KERF), is registered as a non-profit society (under the society registration act, 1860), Government of India with the vision of various accredited vocational courses in healthcare, education, paramedical, yoga, publication, teaching and research activity, with the aim of faster and better dissemination of knowledge, we will be publishing the article more...Original Article
Author Details :
Volume : 2, Issue : 4, Year : 2017
Article Page : 75-80
Abstract
Inflammatory myofibroblastic tumor (IMT) is a lesion of unknown etiology, originally described in lung but can be found at other sites also. Their presence in gall bladder, soft tissue and mesentery is rare. Eight cases of IMT is reported at abnormal sites of mesentery, gall bladder, soft tissue in thigh, disseminated form of IMT involving gall bladder adhered with liver, pylorus and 1st part of duodenum. The characteristic histopathology and immunohistochemistry confirmed the diagnosis of IMT in these cases. Diagnosis of IMT can be challenging and need a multi-disciplinary approach for the correct diagnosis and treatment.
Keywords: Inflammatory, Myofibroblastic, Tumor, Gall bladder, Pylorus, Immunohistochemistry
How to cite : Bhadani P P, Jamal I, Bhadani U K, Shuchismita, Inflammatory Myofibroblastic Tumor (IMT): Report of 8 cases at uncommon sites with literature review. IP Arch Cytol Histopathol Res 2017;2(4):75-80
This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
